Barrow, Hanley, Mewhinney & Strauss’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
106,377
-4,486
-4% -$431K 0.03% 150
2026
Q1
$11.5M Buy
+110,863
New +$12.6M 0.04% 144

Other funds holding CLX

Barrow, Hanley, Mewhinney & Strauss's CLX Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss reduced its Clorox (CLX) stake by 4% in Q2 2026, selling an estimated $431K and leaving 106,377 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #150.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CLX in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.5M in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 106,377 shares of Clorox worth $10.2M as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss sold 4,486 Clorox shares in Q2 2026, an estimated $431K.
  • Clorox made up 0.03% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #150 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Clorox in Q1 2026 and has held it in 2 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Clorox position peaked at $11.5M in Q1 2026.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.